These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36167892)

  • 1. High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test.
    Arita M; Iwai-Itamochi M
    Sci Rep; 2022 Sep; 12(1):16074. PubMed ID: 36167892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antigenic differences between wild and Sabin vaccine strains of poliovirus using the pseudovirus neutralization test.
    Arita M; Iwai-Itamochi M
    Sci Rep; 2019 Aug; 9(1):11970. PubMed ID: 31427704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum.
    Arita M; Iwai M; Wakita T; Shimizu H
    Clin Vaccine Immunol; 2011 Nov; 18(11):1889-94. PubMed ID: 21880850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the neutralizing activities of antibodies in clinical sera against both Sabin and wild-type polio pseudoviruses.
    Liu S; Lu W; Ma S; Guo H; Zhang Z; Li X
    J Virol Methods; 2022 Feb; 300():114376. PubMed ID: 34826519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses.
    Sun M; Li C; Xu W; Liao G; Li R; Zhou J; Li Y; Cai W; Yan D; Che Y; Ying Z; Wang J; Yang H; Ma Y; Ma L; Ji G; Shi L; Jiang S; Li Q
    Clin Infect Dis; 2017 May; 64(10):1317-1325. PubMed ID: 28419204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus.
    Liu S; Song D; Bai H; Lu W; Dai X; Hao C; Zhang Z; Guo H; Zhang Y; Li X
    J Med Virol; 2017 Dec; 89(12):2075-2083. PubMed ID: 28786502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
    Horie H; Sato M; Doi Y; Hashizume S
    Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
    Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
    Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple and safe antibody neutralization assay based on polio pseudoviruses.
    Jiang Z; Liu G; Guo-Yang L; Sun M; Xu K; Ying Z; Wang J; Li X; Li C
    Hum Vaccin Immunother; 2019; 15(2):349-357. PubMed ID: 30273512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010.
    Drexler JF; Grard G; Lukashev AN; Kozlovskaya LI; Böttcher S; Uslu G; Reimerink J; Gmyl AP; Taty-Taty R; Lekana-Douki SE; Nkoghe D; Eis-Hübinger AM; Diedrich S; Koopmans M; Leroy EM; Drosten C
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12889-94. PubMed ID: 25136105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C; Ogawa T; Shirasawa H
    Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: a phase I Trial in healthy adults in Cuba.
    Resik S; Tejeda A; Fonseca M; Alemañi N; Diaz M; Martinez Y; Garcia G; Okayasu H; Burton A; Bakker WA; Verdijk P; Sutter RW
    Vaccine; 2014 Sep; 32(42):5399-404. PubMed ID: 25131734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
    Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
    J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
    Lee CN; Kao CL; Lee CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.
    Green MS; Handsher R; Cohen D; Melnick JL; Slepon R; Mendelsohn E; Danon YL
    Vaccine; 1993; 11(1):75-81. PubMed ID: 8381249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
    Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
    J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains.
    Puligedda RD; Kouiavskaia D; Adekar SP; Sharma R; Devi Kattala C; Rezapkin G; Bidzhieva B; Dessain SK; Chumakov K
    Antiviral Res; 2014 Aug; 108():36-43. PubMed ID: 24824031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.